Kerry Mansell, Hishaam Bhimji, Dean Eurich, & Holly Mansell. (2019). Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis. BMC.
Chicago Style (17th ed.) CitationKerry Mansell, Hishaam Bhimji, Dean Eurich, and Holly Mansell. Correction to: Potential Cost-savings from the Use of the Biosimilars Filgrastim, Infliximab and Insulin Glargine in Canada: A Retrospective Analysis. BMC, 2019.
MLA (9th ed.) CitationKerry Mansell, et al. Correction to: Potential Cost-savings from the Use of the Biosimilars Filgrastim, Infliximab and Insulin Glargine in Canada: A Retrospective Analysis. BMC, 2019.
Warning: These citations may not always be 100% accurate.